First Trust Advisors LP Takeda Pharmaceutical CO LTD Transaction History

First Trust Advisors LP

$95 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$15.03 - $16.32 $1.02 Million - $1.11 Million	68,066 Added 41.24%	233,119 $3.61 Million
Q2 2023 Aug 14, 2023	SELL	$15.57 - $17.11 $3.79 Million - $4.17 Million	-243,710 Reduced 59.62%	165,053 $2.59 Million
Q1 2023 May 15, 2023	BUY	$15.28 - $16.48 $2.75 Million - $2.97 Million	179,939 Added 78.64%	408,763 $6.74 Million
Q4 2022 Feb 09, 2023	SELL	$12.42 - $15.62 $681,547 - $857,147	-54,875 Reduced 19.34%	228,824 $3.57 Million
Q3 2022 Nov 14, 2022	SELL	$12.8 - $28.65 $596,403 - $1.33 Million	-46,594 Reduced 14.11%	283,699 $3.68 Million
Q2 2022 Aug 12, 2022	SELL	$13.12 - $15.03 $6 Million - $6.88 Million	-457,665 Reduced 58.08%	330,293 $4.64 Million
Q1 2022 May 13, 2022	SELL	$13.54 - $15.35 $637,706 - $722,954	-47,098 Reduced 5.64%	787,958 $11.3 Million
Q4 2021 Feb 08, 2022	SELL	$13.17 - $16.4 $13.8 Million - $17.2 Million	-1,045,939 Reduced 55.61%	835,056 $11.4 Million
Q3 2021 Nov 15, 2021	BUY	$16.3 - $17.26 $5.48 Million - $5.8 Million	336,324 Added 21.77%	1,880,995 $30.8 Million
Q2 2021 Aug 16, 2021	SELL	$16.55 - $18.64 $5.22 Million - $5.88 Million	-315,586 Reduced 16.96%	1,544,671 $26 Million
Q1 2021 May 14, 2021	BUY	$16.71 - $19.9 $31.1 Million - $37 Million	1,860,257 New	1,860,257 $34 Million
Q3 2020 Nov 05, 2020	SELL	$17.1 - $19.19 $23.9 Million - $26.8 Million	-1,396,270 Closed	0 $0
Q2 2020 Jul 22, 2020	SELL	$14.59 - $19.5 $635,496 - $849,361	-43,557 Reduced 3.03%	1,396,270 $25 Million
Q1 2020 May 06, 2020	SELL	$13.02 - $20.31 $7.66 Million - $11.9 Million	-588,092 Reduced 29.0%	1,439,827 $21.9 Million
Q4 2019 Feb 03, 2020	SELL	$16.88 - $20.83 $223,052 - $275,247	-13,214 Reduced 0.65%	2,027,919 $40 Million
Q3 2019 Nov 04, 2019	BUY	$16.15 - $17.99 $6.23 Million - $6.94 Million	385,573 Added 23.29%	2,041,133 $35.1 Million
Q2 2019 Jul 30, 2019	SELL	$16.58 - $20.49 $16 Million - $19.8 Million	-967,723 Reduced 36.89%	1,655,560 $29.3 Million
Q1 2019 May 09, 2019	BUY	$16.7 - $21.52 $43.8 Million - $56.5 Million	2,623,283 New	2,623,283 $53.4 Million

Others Institutions Holding TAK

# of Institutions

320

Shares Held

70.4M

Call Options Held

939K

Put Options Held

233K

Capital Research Global Investors Los Angeles, CA

13.1M
Shares

$182 Million
0.04% of portfolio
Mondrian Investment Partners LTD London, X0

7.74M
Shares

$107 Million
1.74% of portfolio
Morgan Stanley New York, NY

4.99M
Shares

$69.1 Million
0.01% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

4.35M
Shares

$60.2 Million
0.03% of portfolio
Goldman Sachs Group Inc New York, NY

3.72M
Shares

$51.5 Million
0.01% of portfolio

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account